Gualtieri F - Search Results

1

Negative inotropic and calcium antagonistic activity of alkyl and arylalkyl phosphonates.

Bellucci C, Gualtieri F, Scapecchi S, Teodori E, Budriesi R, Chiarini A. Bellucci C, et al. Among authors: gualtieri f. Farmaco. 1989 Dec;44(12):1167-91. Farmaco. 1989. PMID: 2634406

2

Semi-rigid analogues of the calcium antagonist verapamil: a molecular modelling study.

Romanelli MN, Dei S, Scapecchi S, Teodori E, Gualtieri F, Budriesi R, Mannhold R. Romanelli MN, et al. Among authors: gualtieri f. J Comput Aided Mol Des. 1994 Apr;8(2):123-34. doi: 10.1007/BF00119863. J Comput Aided Mol Des. 1994. PMID: 8064330

3

Verapamil analogues with restricted molecular flexibility.

Dei S, Romanelli MN, Scapecchi S, Teodori E, Chiarini A, Gualtieri F. Dei S, et al. Among authors: gualtieri f. J Med Chem. 1991 Jul;34(7):2219-25. doi: 10.1021/jm00111a043. J Med Chem. 1991. PMID: 2066995

4

A search for calcium-channel activators in the verapamil series.

Romanelli MN, Gualtieri F, Mannhold R, Chiarini A. Romanelli MN, et al. Among authors: gualtieri f. Farmaco. 1989 May;44(5):449-64. doi: 10.1002/chin.198952109. Farmaco. 1989. PMID: 2476997

5

On the site of interaction of some muscarinic agonists and competitive antagonists.

Gualtieri F, Romanelli MN, Teodori E. Gualtieri F, et al. Farmaco. 1989 Oct;44(10):897-909. Farmaco. 1989. PMID: 2695098 Review.

6

2-pyrrolidinone moiety is not critical for the cognition-enhancing activity of piracetam-like drugs.

Scapecchi S, Martelli C, Ghelardini C, Guandalini L, Martini E, Gualtieri F. Scapecchi S, et al. Among authors: gualtieri f. Farmaco. 2003 Sep;58(9):715-22. doi: 10.1016/S0014-827X(03)00111-3. Farmaco. 2003. PMID: 13679165

7

Design, synthesis, and preliminary pharmacological evaluation of 4-aminopiperidine derivatives as N-type calcium channel blockers active on pain and neuropathic pain.

Teodori E, Baldi E, Dei S, Gualtieri F, Romanelli MN, Scapecchi S, Bellucci C, Ghelardini C, Matucci R. Teodori E, et al. Among authors: gualtieri f. J Med Chem. 2004 Nov 18;47(24):6070-81. doi: 10.1021/jm049923l. J Med Chem. 2004. PMID: 15537361

8

Highly chiral muscarinic ligands: the discovery of (2S,2'R,3'S,5'R)-1-methyl-2-(2-methyl-1,3-oxathiolan-5-yl)pyrrolidine 3-sulfoxide methyl iodide, a potent, functionally selective, M2 partial agonist.

Scapecchi S, Matucci R, Bellucci C, Buccioni M, Dei S, Guandalini L, Martelli C, Manetti D, Martini E, Marucci G, Nesi M, Romanelli MN, Teodori E, Gualtieri F. Scapecchi S, et al. Among authors: gualtieri f. J Med Chem. 2006 Mar 23;49(6):1925-31. doi: 10.1021/jm0510878. J Med Chem. 2006. PMID: 16539379

9

Chiral muscarinic agonists possessing a 1,3-oxathiolane nucleus: enantio- and tissue-selectivity on isolated preparations of guinea-pig ileum and atria and of rat urinary bladder.

Angeli P, Brasili L, Giannella M, Gualtieri F, Picchio MT, Teodori E. Angeli P, et al. Among authors: gualtieri f. Naunyn Schmiedebergs Arch Pharmacol. 1988 Mar;337(3):241-5. doi: 10.1007/BF00168833. Naunyn Schmiedebergs Arch Pharmacol. 1988. PMID: 3393229

10

Enantioselectivity of muscarinic antagonists. 2,2-Dicyclohexyl-5-[(dimethylamino)methyl]-1,3-oxathiolane methiodides and related 3-oxides.

Romanelli MN, Teodori E, Gualtieri F, Angeli P, Brasili L. Romanelli MN, et al. Among authors: gualtieri f. J Med Chem. 1988 Sep;31(9):1698-702. doi: 10.1021/jm00117a006. J Med Chem. 1988. PMID: 3411598

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters